← Leaderboards
Anton Iliuk
Tymora Analytical Operations, Llc
$5,498,296
Attributed
$5,498,296
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,498,296 · 9
By mechanism
R44$4,091,262 · 3
R43$1,407,034 · 6
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Small Business Innovation Research Grant”
- David Heimbrook · Leidos Biomedical Research, Inc.$122,677,088
- Praduman Jain · Vignet, Inc.$106,968,877
- Stephen Lev Hoffman · Sanaria, Inc.$37,771,680
- Eric Baer · Case Western Reserve University$37,136,000
- John B Buse · University Of North Carolina Chapel Hill$23,865,764
- Gary Fanger · Rise Therapeutics, Llc$23,463,293
Research focus
Small Business Innovation Research GrantSamplingUnited States National Institutes Of HealthProteinsAlzheimer&AposDetectionBasePhosphoproteinsBiological MarkersPhosphorylationCostMalignant NeoplasmsTechnologySignal TransductionAnticancer ResearchMonitorCancer TypeReproducibilityRecoverySourcePhase 2 StudyPhase 1 StudyDiagnosticPublic Health
Grant awards (14)
Validation and clinicaldevelopment of plasma EV protein biomarkers for minimally-invasive detection of Alzheimersdisease$854,102
R44 · FY2025 · AG · contact PI
Validation and clinicaldevelopment of plasma EV protein biomarkers for minimally-invasive detection of Alzheimersdisease$815,028
R44 · FY2024 · AG · contact PI
Development of lavage EV protein biomarkers for minimally-invasive detection of endometrial cancer$290,000
R43 · FY2022 · CA · contact PI
Development of non-invasive biomarker discovery and diagnostics approach for bladder cancer based on urine proteome and phosphoproteome$700,000
R44 · FY2021 · CA · contact PI
Development of companion diagnostics for dasatinib-based personalized therapy for T-ALL$310,000
R43 · FY2021 · CA · contact PI
Development of non-invasive biomarker discovery and diagnostics approach for bladder cancer based on urine proteome and phosphoproteome$600,000
R44 · FY2020 · CA · contact PI
Development of non-invasive biomarker discovery and diagnostics approach for bladder cancer based on urine proteome and phosphoproteome$224,999
R44 · FY2019 · CA · contact PI
Development of non-invasive research and diagnostics platform for Alzheimer's disease based on plasma exosomes$215,369
R43 · FY2019 · AG · contact PI
Multiplexed detection and imaging of protein phosphorylation based on soluble nanopolymers$445,595
R44 · FY2016 · CA · contact PI
Multiplexed detection and imaging of protein phosphorylation based on soluble nanopolymers$451,538
R44 · FY2015 · CA · contact PI
Developing gel-based platform for quantitative phosphoproteomics$150,000
R43 · FY2015 · GM · contact PI
Novel soluble nanopolymers for enrichment of low abundant phosphoproteins$144,150
R43 · FY2013 · CA · contact PI
Novel soluble nanopolymers for enrichment of low abundant phosphoproteins$150,000
R43 · FY2012 · CA · contact PI
Multiplexed detection and imaging of protein phosphorylation based on soluble nan$147,515
R43 · FY2012 · EB · contact PI